lovastatin has been researched along with DDPAC in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, R; Ma, T; Xu, DE | 1 |
| Chao, HW; Chen, CY; Hsueh, YP; Lee, MJ; Shih, YT; Wang, HF | 1 |
2 other study(ies) available for lovastatin and DDPAC
| Article | Year |
|---|---|
Lovastatin suppresses the aberrant tau phosphorylation from FTDP-17 mutation and okadaic acid-induction in rat primary neurons.
Topics: Alzheimer Disease; Animals; Cells, Cultured; Frontotemporal Dementia; Lovastatin; Mutation; Neurons; Okadaic Acid; Phosphorylation; Rats, Sprague-Dawley; tau Proteins | 2015 |
Valosin-containing protein and neurofibromin interact to regulate dendritic spine density.
Topics: Adenosine Triphosphatases; Animals; CA1 Region, Hippocampal; Cell Cycle Proteins; Cells, Cultured; Cholesterol; Contracture; Dendrites; Frontotemporal Dementia; Humans; Learning Disabilities; Lovastatin; Mice; Mice, Knockout; Mutation, Missense; Myositis, Inclusion Body; Neurofibromatosis 1; Neurofibromin 1; Ophthalmoplegia; Osteitis Deformans; Point Mutation; Protein Interaction Mapping; Protein Structure, Tertiary; Pyramidal Cells; Rats; Synapses; Valosin Containing Protein | 2011 |